IDEXX Laboratories expands UK testing as IDEXX Laboratories stock costs EUR 460.65
Published on 10/04/2026 at 17:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
On September 17, 2026, IDEXX Laboratories announced the expansion of its Faecal Dx antigen testing platform in the United Kingdom to include taeniid tapeworm detection, according to an IDEXX Laboratories release. At 5:48 p.m. CEST on October 4, 2026, IDEXX Laboratories stock cost EUR 460.65 in weekend trading at Lang & Schwarz, unchanged from the EUR 460.65 close of the last Xetra trading day on October 2, 2026.
Weekend trading
Lang & Schwarz showed a price of EUR 460.65 at 5:48 p.m. CEST on October 4, 2026. The quote was 0.00 percent from the close of EUR 460.65 at Lang & Schwarz on October 2, 2026. The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CET/CEST is shown by the continuously updated real-time quote of IDEXX Laboratories stock.
Last Xetra trading day
The reference close at Lang & Schwarz was EUR 460.65 on October 2, 2026. Xetra and the primary exchanges are closed during the publication window.
Testing platform expansion
The September 17 release said the United Kingdom menu now includes taeniid tapeworm detection at no additional cost for current Faecal Dx antigen testing panels and profiles used by IDEXX Reference Laboratories customers. The release said positive results will automatically initiate a complimentary follow-up Echinococcus RealPCR test. IDEXX also stated that the platform detects seven clinically relevant intestinal parasite groups, including taeniid tapeworms, according to the company announcement.
CoVetAI acquisition
On September 16, 2026, IDEXX announced the acquisition of CoVetAI, a provider of AI-native ambient listening and clinical workflow software for veterinary practices. IDEXX said CoVet would be integrated into its software ecosystem, while financial terms were not disclosed, according to a separate company release.
Next Xetra session
The next Xetra session is scheduled for October 5, 2026.
